Croda International Plc operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Croda International Plc with three other
companies in this sector in the United Kingdom:
sales of £786.93 million [US$1.02 billion]
of which 100%
was Buprenorphine Based Drugs),
(£447.50 million [US$580.42 million]
of which 37%
was Licensing & Biotechnology), and
Hikma Pharmaceuticals PLC
(£1.45 billion [US$1.88 billion]
of which 40%
was Injectable Pharmaceuticals).
Croda International Plc reported sales of £1.24 billion (US$1.61 billion)
December of 2016.
increase of 15.0%
versus 2015, when the company's sales were £1.08 billion.
Sales of Life Sciences saw an increase
26.3% in 2016, from
£231.30 million to £292.20 million.